Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder

European Child & Adolescent Psychiatry
Philip HazellDavid Michelson

Abstract

To examine the influence of comorbid oppositional defiant disorder (ODD) on the relative risk (RR) of relapse during 9 months of treatment with atomoxetine for attention-deficit/hyperactivity disorder (ADHD). Four hundred and sixteen children and adolescents with ADHD whose symptoms remitted during initial 10-week, open-label atomoxetine treatment were randomly assigned to continue with atomoxetine or placebo. In all, 43% met criteria for comorbid ODD. A total of 17% of patients with comorbid ODD relapsed (CGI-Severity score >or= 3 and ADHD Rating Scale total score of 90% or more of baseline at study entry on two consecutive visits) during atomoxetine treatment, compared with 26% of patients without comorbid ODD (RR 0.67, 95% CI 0.42-1.06). Mean time to relapse was not significantly different [mean (SE) days to relapse, ADHD/ +ODD: 215 (7.38); ADHD/-ODD: 211 (7.61); log rank p = 0.08]. This finding is placed within the context of atomoxetine affording an overall protection against relapse compared with placebo (RR 0.59, 95% CI 0.43-0.80). Comorbid ODD does not influence the rate of relapse of patients with ADHD during longer-term treatment with atomoxetine. Atomoxetine protects against the relapse of ADHD symptoms regardless of...Continue Reading

References

Nov 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·S R Pliszka
Apr 1, 1997·Journal of Paediatrics and Child Health·P Hazell
May 20, 1998·The American Journal of Psychiatry·T SpencerL Seidman
Dec 11, 1999·Archives of General Psychiatry·E Taylor
Jul 29, 2000·Biological Psychiatry·S V FaraoneM C Monuteaux
Feb 24, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·P S Jensen
Feb 24, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·P S JensenB Vitiello
Jan 5, 2002·The American Journal of Psychiatry·Joseph BiedermanMary Ann Johnson
Jul 11, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher J KratochvilDavid Michelson
Nov 29, 2002·Pediatrics·Joseph BiedermanUNKNOWN Atomoxetine ADHD Study Group
Dec 25, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·John T WalkupUNKNOWN Research Units on Pediatric Psychopharmacology Anxiety Study Group
Jan 28, 2003·Biological Psychiatry·David MichelsonDenái Milton
Mar 15, 2003·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Tobias BanaschewskiAribert Rothenberger
Jul 23, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Philip L Hazell, John E Stuart
Jun 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·David MichelsonJoseph Biederman

❮ Previous
Next ❯

Citations

May 9, 2006·European Child & Adolescent Psychiatry·Tobias BanaschewskiEric Taylor
Jan 22, 2013·Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·Stephanie L CardoosStephen P Hinshaw
Dec 29, 2009·Journal of Child and Adolescent Psychopharmacology·Linda A WietechaKory Schuh
Jun 27, 2009·Neuropsychiatric Disease and Treatment·Paul HammernessDaniel Geller
Dec 2, 2010·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Philip Hazell
Jul 21, 2010·Current Medical Research and Opinion·Keith SaylorMichael Greenbaum
May 3, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gigi H H van de Loo-NeusJan K Buitelaar
Sep 1, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Grazia Dell'AgnelloUNKNOWN LYCY Study Group
Nov 26, 2010·Accident; Analysis and Prevention·Tova Rosenbloom, Boaz Wultz
Jan 15, 2015·Scandinavian Journal of Occupational Therapy·Chris BruceMichael P Dillon
Aug 29, 2016·The International Journal of Risk & Safety in Medicine·Shannon HughesRebekah Johnson
Apr 13, 2017·Attention Deficit and Hyperactivity Disorders·Anselm B M FuermaierOliver Tucha
Jul 6, 2014·Journal of Attention Disorders·Joseph R HolbrookRobert E McKeown
May 1, 2012·Journal of Attention Disorders·Annie A GarnerDespina Stavrinos
Mar 2, 2012·Journal of Attention Disorders·Philip AshersonPaul Hodgkins
Apr 5, 2013·Canadian Journal of Occupational Therapy. Revue Canadienne D'ergothérapie·Miriam MonahanPatty V Helsel
Dec 8, 2015·Journal of Attention Disorders·Gregory A FabianoWilliam E Pelham
Oct 1, 2015·Journal of Neural Transmission·Anselm B M FuermaierOliver Tucha
May 31, 2017·Journal of Child and Adolescent Psychopharmacology·Sharon B WigalDonna Palumbo
Sep 10, 2009·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Andrea G LudolphJörg M Fegert
Oct 31, 2009·Expert Opinion on Pharmacotherapy·Daniel Coury
Oct 11, 2019·Journal of Clinical Medicine·Sarah Kittel-SchneiderAndreas Reif
Jun 12, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·R R KielingL A Rohde
Oct 16, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·E SobanskiP Strohbeck-Kühner
Jan 5, 2011·Journal of Paediatrics and Child Health·Daryl EfronVicki Anderson
Feb 5, 2015·Journal of Developmental and Behavioral Pediatrics : JDBP·Scott E HadlandSion K Harris
Nov 8, 2013·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Sherrilene ClassenYanning Wang
Aug 29, 2014·Evidence-based Mental Health·Flaura Koplin Winston, Daniel Romer
Aug 15, 2015·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Flaura K WinstonDaniel Romer
Feb 13, 2010·Neuroscience and Behavioral Physiology·L S ChutkoK A Aitbekov
May 29, 2013·Attention Deficit and Hyperactivity Disorders·Julia MerktCaterina Gawrilow
Apr 5, 2011·Attention Deficit and Hyperactivity Disorders·Caterina GawrilowMike Wendt
Jul 1, 2014·Journal of Clinical Psychopharmacology·Joris C Verster, Thomas Roth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.